|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of Registrant as Specified in Its Charter)
|
|
|
|
|
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
|
|
|
|
|
|
|
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code:
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each Class |
Trading Symbol(s) |
Name of each exchange on which registered |
|
|
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 21, 2020, HealthStream, Inc. (the “Company”) held its annual meeting of shareholders (the “Annual Meeting”). The final results of the proposals submitted to shareholder vote at the Annual Meeting, which proposals were described in more detail in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 9, 2020, are set forth below.
|
|
(1) |
Election of three directors in Class II for a term of three years and until their successors are duly elected and qualified: |
|
|
FOR |
|
WITHHELD |
|
BROKER NON VOTES |
|
Jeffrey L. McLaren |
16,595,454 |
|
10,981,448 |
|
2,779,699 |
|
Michael D. Shmerling |
26,610,379 |
|
966,523 |
|
2,779,699 |
|
Linda E. Rebrovick |
25,873,348 |
|
1,703,554 |
|
2,779,699 |
|
|
|
|
|
|
|
In addition to the foregoing directors, the remaining directors not up for re-election at the Annual Meeting continue to serve on the Board of Directors.
|
|
(2) |
Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020: |
|
FOR |
|
AGAINST |
|
ABSTAIN |
|
BROKER NON VOTES |
|
29,494,545 |
|
849,402 |
|
12,654 |
|
0 |
|
(3)Adoption of a non-binding advisory resolution on the Company’s executive compensation as described in the Proxy Statement (“say-on-pay”): |
|
FOR |
|
AGAINST |
|
ABSTAIN |
|
BROKER NON VOTES |
|
26,806,100 |
|
754,634 |
|
16,168 |
|
2,779,699 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
Date: May 21, 2020 |
HEALTHSTREAM, INC. |
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Michael M. Collier |
|
|
|
Michael M. Collier Senior Vice President, Corporate Development and General Counsel |
|
|
|
|